Skip to Navigation | Skip to Main Content | Skip to Site Map | Mobile Site

Senate Tracker: Sign Up | Login

The Florida Senate

CS/CS/CS/HB 543 — Uterine Fibroid Research and Education

by By Health and Human Services Committee; Appropriations Committee; Professions and Public Health Committee; and Rep. Omphroy and others (CS/CS/SB 1010 by Appropriations Committee; Health Policy Committee; and Senator Gibson)

This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.

Prepared by: Health Policy Committee (HP)

The bill requires the Department of Health (DOH) to develop and maintain an electronic database of information related to uterine fibroids. The purpose of the database is to encourage research relating to the diagnosis and treatment of uterine fibroids and to ensure that women are provided with the relevant information and health care necessary to prevent and treat uterine fibroids.

The bill requires specified health care providers to submit information to the DOH regarding the diagnosis or treatment of women with uterine fibroids for inclusion in the database. The bill defines health care providers as physicians or physician assistants licensed under chs. 458 or 459, F.S., and advanced practice registered nurses licensed under ch. 464, F.S.

The database must include, but need not be limited to:

  • Incidence and prevalence of women diagnosed with uterine fibroids in the state.
  • Demographic attributes of women diagnosed with uterine fibroids in the state.
  • Treatments and procedures for uterine fibroids used by health care providers in the state.

The bill prohibits the database from including personal identifying information. The bill requires the DOH to develop and include information related to uterine fibroids in its women’s health care educational materials made available to the public under preexisting law. Such information in the materials must include possible risk factors for developing uterine fibroids and the range of available treatment options that are considered alternatives to a hysterectomy.

The bill appropriates $121,852 in recurring funds and $681,048 in nonrecurring funds from the General Revenue Fund and one full-time equivalent position to the DOH for the purpose of implementing the bill.

If approved by the Governor, these provisions take effect July 1, 2022.

Vote: Senate 37-0; House 113-0